Deal Details

Sale to Model N

Technology & Services

Sale to Model N

Summary

Baird served as exclusive financial adviser to Revitas, Inc. on this transaction

About

Revitas, Inc. (“Revitas”), a portfolio company of LLR Partners, was recently acquired by Model N, Inc. (“Model N”) (NYSE: MODN) in a transaction valued at $60 million.

Revitas is the leading provider of enterprise-class solutions for channel and contract management for the life sciences industry. Revitas solutions, which are both on-premise and cloud-based, enable organizations to accelerate revenue, calculate pricing and rebates accurately and attain maximum value from contracts. For over 25 years, Revitas has empowered companies in channel intensive industries to achieve best-in-class performance and sustainable competitive advantage. Revitas is headquartered in Philadelphia, Pennsylvania.

LLR Partners is a middle market private equity firm providing capital and strategic guidance to growth companies. LLR invests in a broad range of industries, with an emphasis on software, tech-enabled services and healthcare. Founded in 1999 and with more than $2 billion raised across four funds, LLR is a flexible provider of capital for growth, recaps and buyouts. LLR Partners is headquartered in Philadelphia, Pennsylvania.

Model N is a leader in revenue management solutions. Model N’s solutions drive mission-critical business processes such as configure, price and quote (CPQ), contract and rebate management, business intelligence and regulatory compliance, and thereby transform the revenue lifecycle from a series of disjointed operations into a strategic end-to- end process. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in life sciences, technology and manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Microchip Technology and ON Semiconductor. Model N is headquartered in Redwood City, California.

The acquisition unites more than 40 years of combined revenue management experience, more than 80 life sciences customers and a presence in 10 major locations around the world. The integration of Revitas enables Model N to accelerate innovation across a broad set of applications to the benefit of the life sciences industry. Revenue management is becoming a strategic imperative as the life sciences industry experiences unprecedented and evolving global regulation, increasing price transparency, a transition from traditional consumption-based pricing to new outcome-based models and continued M&A activity.

Technology & Services

Sale to Model N